(Q38212550)

31 August 2017

title

The CD4 T cell response to respiratory syncytial virus infection (English)

1 reference

31 August 2017

author

Allison F. Christiaansen

object named as

Allison F Christiaansen

1

0 references

Steven M Varga

object named as

Steven M Varga

4

0 references

author name string

Cory J Knudson

2

1 reference

31 August 2017

Kayla A Weiss

3

1 reference

31 August 2017

publication date

1 August 2014

1 reference

31 August 2017

1 reference

31 August 2017

volume

59

1 reference

31 August 2017

issue

1-3

1 reference

31 August 2017

page(s)

109-117

1 reference

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

The histopathology of fatal untreated human respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-4Rα on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-10 and RANTES are elevated in nasopharyngeal secretions of children with respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

21 January 2018

Th9 and allergic disease

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Type 2 innate lymphoid cells: new players in asthma and allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Activation of the granzyme pathway in children with severe respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Comparison of lung histopathology and bronchoalveolar lavage cytology in mice and cotton rats infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

NK Cell Deficiency Predisposes to Viral-Induced Th2-Type Allergic Inflammation via Epithelial-Derived IL-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-014-8540-1

Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage

21 January 2018

1 reference

12 December 2020

Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics

1 reference

12 December 2020

Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls

1 reference

12 December 2020

Risk of primary infection and reinfection with respiratory syncytial virus

1 reference

12 December 2020

Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells

1 reference

12 December 2020

The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

1 reference

12 December 2020

Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity

1 reference

12 December 2020

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

12 December 2020

Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection.

1 reference

12 December 2020

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

1 reference

12 December 2020

IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma

1 reference

12 December 2020

10.1007/S12026-014-8540-1

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1015317293

0 references

1 reference